Shukra Pharmaceuticals Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 29.83 million compared to INR 16.76 million a year ago. Revenue was INR 53.86 million compared to INR 17.75 million a year ago. Net income was INR 0.192 million compared to INR 0.922 million a year ago. Basic earnings per share from continuing operations was INR 0.12 compared to INR 0.59 a year ago. Diluted earnings per share from continuing operations was INR 0.12 compared to INR 0.59 a year ago. For the six months, sales was INR 59.45 million compared to INR 27.85 million a year ago. Revenue was INR 85.73 million compared to INR 30.24 million a year ago. Net income was INR 0.563 million compared to INR 1.11 million a year ago. Basic earnings per share from continuing operations was INR 0.36 compared to INR 0.71 a year ago. Diluted earnings per share from continuing operations was INR 0.36 compared to INR 0.71 a year ago.